Back
Reviva Pharmaceuticals Holdings Stock Predictions
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.
Sell
28
RVPH
Reviva Pharmaceuticals Holdings
Last Price:
1.24
Seasonality Move:
-14.71%
7 Day Trial
ALL ACCESS PASS
$
7
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.Reviva Pharmaceuticals Holdings Stock Forecast
-
Is Reviva Pharmaceuticals Holdings Stock Undervalued?
The current Reviva Pharmaceuticals Holdings [RVPH] share price is $1.32. The Score for RVPH is 28, which is 44% below its historic median score of 50, and infers higher risk than normal. - RVPH is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Reviva Pharmaceuticals Holdings Stock Go Up Next Year?
Data Unavailable
Reviva Pharmaceuticals Holdings Stock Rating
Data Unavailable
Reviva Pharmaceuticals Holdings Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
revivapharma.com
52-Week Data
52-Week High:
6.22
52-Week Low:
0.60
Prediction Charts
Market Cap:
43.68M
Price in USD:
1.32
Volume:
3.97M
Beta:
-0.04
Technical Analysis
SMA50:
1.22
SMA100:
1.14
SMA200:
2.05
52-Wk Change:
-77.04%
Stock Predictions
-
Is Reviva Pharmaceuticals Holdings stock public?
Yes, Reviva Pharmaceuticals Holdings is a publicly traded company. -
What is the Reviva Pharmaceuticals Holdings stock quote today?
The Reviva Pharmaceuticals Holdings stock price is 1.32 USD today. -
How to buy Reviva Pharmaceuticals Holdings stock online?
You can buy Reviva Pharmaceuticals Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Oct-24 | 1.25 | 1.14 | 1.27 | 1.10 |
| Oct-25 | 1.15 | 1.14 | 1.22 | 1.12 |
| Oct-28 | 1.15 | 1.20 | 1.20 | 1.10 |
| Oct-29 | 1.22 | 1.18 | 1.22 | 1.13 |
| Oct-30 | 1.18 | 1.16 | 1.21 | 1.15 |
| Oct-31 | 1.12 | 1.12 | 1.15 | 1.07 |
| Nov-1 | 1.15 | 0.98 | 1.15 | 0.96 |
| Nov-4 | 0.97 | 0.99 | 1.07 | 0.97 |
| Nov-5 | 0.99 | 0.92 | 1.04 | 0.90 |
| Nov-6 | 0.94 | 0.93 | 0.97 | 0.90 |
| Nov-7 | 0.95 | 0.94 | 0.99 | 0.93 |
| Nov-8 | 0.94 | 0.91 | 0.99 | 0.91 |
| Nov-11 | 0.96 | 1.00 | 1.10 | 0.88 |
| Nov-12 | 1.10 | 1.32 | 1.44 | 1.10 |
Reviva Pharmaceuticals Holdings Earnings
Data Unavailable
Reviva Pharmaceuticals Holdings Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and an increase next year of $0.14 per share.
* Reviva Pharmaceuticals Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.